Price
Target price
€0.40
€0.40
2.330%
0.009
2.330%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Tempramed Technologies Ltd. Stock
There is an upward development for Tempramed Technologies Ltd. compared to yesterday, with an increase of €0.009 (2.330%).
Pros and Cons of Tempramed Technologies Ltd. in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
B****
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
News
TempraMed Announces Granted Indian Design Patent for VIVI Cap Smart Product
Another major milestone in its continuous global IP strategy, advancing protection of VIVI Cap Smart across international markets
Highlights
- Granted Patent covers the design
TempraMed Partners with Super-Pharm, Israel’s Leading Pharmacy Chain to Commence a National Product Roll Out Strategy
Super-Pharm operates nationwide, serving millions of consumers annually
Vancouver, BC - February 10, 2026 - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) (“TempraMed” or the “Company
TempraMed Launches National Brick and Mortar Pharmacy Roll Out, Shipping Products to Maccabi Pharmacies Across Israel
Key Commercialization Milestone in Retail Pharmacy Network that Serves Over 2.8 Million Insured Members
Vancouver, BC – February 6, 2026 – TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY)